TITLE

Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: Results of a Delphi survey

AUTHOR(S)
Yu, Shengsheng; Galanter, William L.; DiDomenico, Robert J.; Borkowsky, Shane; Schiff, Gordon D.; Lambert, Bruce L.
PUB. DATE
March 2011
SOURCE
American Journal of Health-System Pharmacy;3/1/2011, Vol. 68 Issue 5, p407
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Combinations of drugs and laboratory values ("drug-laboratory pairs") that represent practical high-priority targets for potential use in a daily asynchronous inpatient clinical decision-support (CDS) alert report were identified. Methods. A list of 654 drug-laboratory pairs compiled through a literature review was evaluated by a multidisciplinary expert panel in a modified Delphi procedure. After initial evaluation to narrow the list to 89 drug-laboratory pairs, panelists used Likert scales to rate the remaining pairs on six dimensions (frequency of alert, likelihood of harm, severity of harm, preventability, ameliorability, and global impression of usefulness) in Delphi survey rounds until consensus emerged. Final selection of pairs for potential use as CDS tools was based on global-impression-of-usefulness scores. Correlations between impression of usefulness and other evaluative dimensions were determined. Results. The Delphi process yielded a final list of 24 high-priority drug-laboratory pairs. The highest-ranked pairs were heparin-low platelet count, potassium supplement-high serum potassium, angiotensin-converting-enzyme inhibitor-high serum potassium, and heparin-positive heparin platelet factor 4 antibody test. Medications on the final list included nine anticoagulants, six cardiologic agents, four antimicrobials, and two electrolytes. Most of the selected drug-laboratory pairs related to renal function, serum potassium levels, hematologic results, or pregnancy. Panelists' impression of usefulness was significantly correlated with severity-of-harm ratings (p < 0.0001). Conclusion. Expert review of drug- laboratory value pairs for potential inclusion in an asynchronous monitoring program yielded 24 high-priority and practical pairs for monitoring. About 25% of the pairs had not been the focus of previous laboratory-pharmacy CDS at the study panelists' home institutions.
ACCESSION #
58638989

 

Related Articles

  • Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. Andersson, M.; Böttiger, Y.; Lindh, J.; Wettermark, B.; Eiermann, B. // European Journal of Clinical Pharmacology;Mar2013, Vol. 69 Issue 3, p565 

    Purpose: To investigate the impact of the integration of the drug-drug interaction database SFINX into primary health care records on the prevalence of potentially serious drug-drug interactions. Methods: The study was a controlled before-and-after study on the prevalence of potential drug-drug...

  • Can Clinical Decision Support Improve Medication Safety in the Ambulatory Setting? Keber, Barbara // New York Family Medicine News;Fall2014, p12 

    The article presents an overview of the Palliative and Therapeutic Harmonization (PATH) model, to furnish frail older people with outpatient consultative services, and the need for family physicians to join the scheme in the U.S.

  • ABC to unveil F1RSTAnalytics, 'insights at your fingertips' tool.  // Medical Device Daily;10/11/2013, Vol. 17 Issue 197, p8 

    The article reports on the plan of Anesthesia Business Consultants, a physician billing and practice management company, to launch its FIRSTAnalytics tool at the American Society of Anesthesiologists' (ASA) annual convention in San Francisco, California, in October 2013.

  • Using big data to prevent drug errors. Rice, Sabriya // Modern Healthcare;7/13/2015, Vol. 45 Issue 28, p0034 

    The article discusses Israel-based firm MedAware, co-founded by Dr. Gidi Stein, which offers big-data software platform integrated with the electronic health record to detects medication error and the firm's software is being used in Brigham and Women's Hospital in Boston, Massachusetts. It...

  • The expenditure of computer-related worktime using clinical decision support systems in chronic pain therapy. Hecht, Timm; Bundscherer, Anika C.; Lassen, Christoph L.; Lindenberg, Nicole; Graf, Bernhard M.; Ittner, Karl-Peter; Wiese, Christoph H. R. // BMC Anesthesiology;Aug2015, Vol. 15 Issue 1, p1 

    Background: Estimate the expenditure of computer-related worktime resulting from the use of clinical decision support systems (CDSS) to prevent adverse drug reactions (ADR) among patients undergoing chronic pain therapy and compare the employed check systems with respect to performance and...

  • Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification. Frölich, Thomas; Zorina, Olesya; Fontana, Andrea; Kullak-Ublick, Gerd; Vollenweider, Andreas; Russmann, Stefan // European Journal of Clinical Pharmacology;Dec2011, Vol. 67 Issue 12, p1273 

    Purpose: Our aim was to study drug interactions and dose adjustments in patients with renal impairment in the discharge medication of surgical inpatients and to evaluate the strengths and limitations of clinical decision support software (CDSS) for this task. Methods: This was a cross-sectional...

  • SEEKING Clinical Decision-Support Standards. Chapman, Susan // For the Record (Great Valley Publishing Company, Inc.);10/8/2012, Vol. 24 Issue 18, p14 

    The article discusses the clinical decision support (CDS) interventions which offers guidance on diagnosis, treatment, and exchange information for medical practices. Stephen Claypool, vice president of clinical development and informatics mentions that the concept of CDS is to extends...

  • Keeping Current: Clinical Decision Support Systems. Forrest, Jane L; Miller, Syrene A.; Miller, Greg // Journal of Dental Hygiene;Winter2012, Vol. 86 Issue 1, p18 

    The article reports on topics which were discussed at a workshop which was held at the second North American Global Dental Hygiene Research Conference, which was held in Bethesda, Maryland on October 20-22, 2011 and was designed to introduce participants to basic evidence-based decision making...

  • Elsevier launches clinical insight engine.  // Information World Review;5/30/2012, p9 

    The article discusses the launch of ClinicalKey, a clinical insight engine of scientific and medical publishing company, Elsevier.

  • CDS TOOLS AND PATIENT SATISFACTION. Schaefer, Juliann // For the Record (Great Valley Publishing Company, Inc.);Apr2013, Vol. 25 Issue 6, p6 

    The article reports a study which revealed that doctors' use of computer-based clinical decision-support (CDS) technology tools led to decreased patient satisfaction. It mentions that patients gave significantly lower ratings on diagnostic ability, professionalism, and overall satisfaction to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics